Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07114718 · ClinicalTrials.gov registry record · NA
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
A NA study of Congenital Heart Disease and Congenital Heart Disease (CHD), sponsored by Starlight Cardiovascular.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 7
- Study locations
NCT07114718 is a NA study of Congenital Heart Disease and Congenital Heart Disease (CHD) that is actively recruiting participants, run by Starlight Cardiovascular. The registered enrollment target is 35 participants, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (93% lower). The trial reports 7 study locations across 5 states.
The verdict
NCT07114718, a NA study of Congenital Heart Disease and Congenital Heart Disease (CHD), is actively recruiting participants, sponsored by Starlight Cardiovascular.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 7
- Study locations
Study Summary
Starlight Cardiovascular, Inc. is sponsoring a prospective, multi-center, study to evaluate safety and effectiveness of the Lifeline Ductus Arteriosus Stent System. The study device is a stent that is designed to maintain patency of the Ductus Arteriosus for children who need blood flow through that part of the heart.
Conditions Studied
Interventions
- DEVICE Ductus Arteriosus Stent
Study Locations (7)
California
- UCLA Mattel Children's - Los Angeles
- Leland Stanford Junior University - Stanford
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- Nationwide Children's Hospital - Columbus
Colorado
- Children's Hospital Colorado - Aurora
Massachusetts
- Boston Children's Hospital - Boston
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2025-12-03 |
| Est. Completion | 2028-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07114718
The ClinicalTrials.gov registry entry for NCT07114718 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (93% lower). The listed sponsor is Starlight Cardiovascular, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Ductus Arteriosus Stent is the first listed.
NCT07114718 reports 7 study locations spanning 5 distinct geographic areas - top geographies include California, Ohio, Colorado.
Frequently Asked Questions
What is clinical trial NCT07114718 about?
NCT07114718 is a clinical study titled "Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study". Starlight Cardiovascular, Inc. is sponsoring a prospective, multi-center, study to evaluate safety and effectiveness of the Lifeline Ductus Arteriosus Stent System. The study device is a stent that is designed to maintain patency of the Ductus Arteriosus for children who need blood flow through that...
What is the current status of trial NCT07114718?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2025-12-03. Estimated completion is 2028-04.
What conditions does trial NCT07114718 study?
This clinical trial studies the following conditions: Congenital Heart Disease, Congenital Heart Disease (CHD).
What interventions are being tested in trial NCT07114718?
The interventions under investigation include: Ductus Arteriosus Stent (DEVICE).
Who is sponsoring clinical trial NCT07114718?
This trial is sponsored by Starlight Cardiovascular, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07114718 being conducted?
This trial has 7 study locations across California, Colorado, Massachusetts, Ohio, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fontan Fitness Trial
RECRUITING · NA
-
Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery
RECRUITING · NA
-
The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study
RECRUITING · NA
-
A Study of Hemodynamic Cardiopulmonary Exercise for CHD
RECRUITING · NA
-
Ventripoint Single Ventricle Study
RECRUITING · NA
-
Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.